发明名称 STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER
摘要 An orally deliverable pharmaceutical composition comprises a Bcl-2 family protein inhibitory compound, e.g., ABT-263, a heavier-chalcogen antioxidant and a substantially non-aqueous lipid carrier, wherein said compound and said antioxidant are in solution in the carrier. The composition is suitable for oral administration to a subject in need thereof for treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.
申请公布号 EP2424499(A1) 申请公布日期 2012.03.07
申请号 EP20100717961 申请日期 2010.04.30
申请人 ABBOTT LABORATORIES 发明人 CATRON, NATHANIEL;FICKES, MICHAEL;FISCHER, CRISTINA;HAIGHT, ANTHONY R.;HEEMSTRA, KATHERINE;SANZGIRI, YESHWANT;SCHMITT, ERIC;TONG, PING;ZHANG, GEOFF;ZHOU, DELIANG
分类号 A61K9/00;A61K9/48;A61K31/5377;A61K47/00;A61K47/02;A61K47/14;A61K47/20 主分类号 A61K9/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利